Global Viral Hepatitis and Retrovirus Diagnostic Tests Industry

Global Viral Hepatitis and Retrovirus Diagnostic Tests Industry

  • April 2021 •
  • 127 pages •
  • Report ID: 5960424 •
  • Format: PDF
Abstract:
- Global Viral Hepatitis and Retrovirus Diagnostic Tests Market to Reach $5.9 Billion by 2027
- Amid the COVID-19 crisis, the global market for Viral Hepatitis and Retrovirus Diagnostic Tests estimated at US$3.3 Billion in the year 2020, is projected to reach a revised size of US$5.9 Billion by 2027, growing at a CAGR of 8.5% over the period 2020-2027.
- The U.S. Market is Estimated at $898.1 Million, While China is Forecast to Grow at 11.4% CAGR
- The Viral Hepatitis and Retrovirus Diagnostic Tests market in the U.S. is estimated at US$898.1 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.2 Billion by the year 2027 trailing a CAGR of 11.4% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.8% and 7.3% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 6.6% CAGR.

- Select Competitors (Total 31 Featured) -
  • Abbott Diagnostics
  • Amkay Products
  • AOV International
  • Apothecaries Sundries Manufacturing
  • BD
  • Beckman Coulter
  • Bhat Bio-tech
  • BioMerieux
  • Bioneovan
  • Bio-Rad
  • Cepheid
  • Chembio
  • DiaSorin
  • Enzo Biochem
  • Fujirebio
  • Gemc Technology
  • Grifols
  • Hangzhou Deangel Biological Engineering
  • Hangzhou Heo Bio-Tech
  • Hologic
  • Horiba
  • Innovation Biotech
  • Jaksh Enterprises
  • Krishco Medical Products
  • Roche Diagnostics